Teligent, Inc. (NASDAQ:TLGT) headquartered in Buena, will host a conference call for the investment community to discuss the 2Q20 financial results on 19th August 2020 at 8:00 AM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.teligent.com
Earnings Expectation
Teligent, Inc. is reporting second quarter financial results on Wednesday 19th August 2020, after market close.
According to analysts surveyed by Thomson Reuters, TLGT is expected to report 2Q20 loss of $ 1.7 per share from revenue of $ 10.03 million.
For the full year, analysts anticipate top line of $ 49.40 million, while looking forward to loss of $ 6.2 per share bottom line.
Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. It offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. The company is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets.
